Paradigm Biopharmaceuticals Limited

ASX:PAR.AX

0.22 (AUD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q2
Operating Activities:
Net Income -9.695-48.958-20.043-31.867-12.265-26.985-13.567-20.73-7.195-5.104-11.227-4.4-2.617-3.573-1.457-2.818-1.502-1.423-0.960-0.605
Depreciation & Amortization 0.0730.0730.0770.0770.0960.0970.1070.1030.140.0730.00800.01500.01700.0030000
Deferred Income Tax 0-3.846-8.43912.179-7.3537.587-6.5750.153-0.723-0.79-1.24500.13900.30601.2830000
Stock Based Compensation 0.370.830.0170.921.6911.5791.8541.3520.7870.4912.04200.78100.17900.05100.48400.265
Change In Working Capital 1.452-3.046-7.58812.921-4.8339.272-3.73-0.006-0.0870.054-0.8430-0.9910-0.4850-1.33500.00400
Accounts Receivables 2.328-0.62-6.5426.4530.3341.454-5.010.012-0.2040.226-0.7970-0.920-0.4850-1.33500.00400
Change In Inventory 000000000000000000000
Change In Accounts Payables -7.091-2.249-1.7266.799-5.8037.9050.5031.6990000000000000
Other Working Capital -0.876-0.1780.681-0.3310.636-0.0870.777-1.7170.117-0.172-0.0450-0.07100000000
Other Non Cash Items -7.1223.9248.543-11.9847.186-8.2786.262-0.1532.994-0.7856.8272.435-1.9692.3410.447-0.3530.0190.5990.0050-0.396
Operating Cash Flow -14.922-51.023-27.432-17.754-15.477-16.728-15.648-19.281-4.201-5.889-4.4-1.965-4.781-1.233-1.299-3.171-2.764-0.823-0.4670-0.736
Investing Activities:
Investments In Property Plant And Equipment 14.92200000-0.011-0.021-0.032-0.099-0.0210-0-0.003-0.004-0.016-0.01-0.003000
Acquisitions Net 00000000000000000.41-0.41000
Purchases Of Investments 000000000000000000000
Sales Maturities Of Investments -0.0460.046-0.0460.046000.701.953.80400000000000
Other Investing Activites -0.0460.046-0.0460.046000.7-0.0011.9523.798-6.504-0.0010.092-0.104-1.123-0.78-0.599-0.153-0.2020-0.036
Investing Cash Flow -0.0460.046-0.0460.046-39.67471.0350.689-0.0211.9183.705-6.521-0.0010.092-0.107-1.127-0.795-0.199-0.567-0.2020-0.036
Financing Activities:
Debt Repayment 0-0.051-0.284-0.132-0.126-0.079-0.104-0.1040-0.03700000000000
Common Stock Issued -0.07528.354062.223000.5820.54233.4180.83373.3240000000000
Common Stock Repurchased 000000000000000000-1.23500
Dividends Paid 000000000000000000000
Other Financing Activities -0.12628.3540.23662.3550.0570.0790.4160.6461.8960.81973.3249.4541.1334.751-0.0085.9930.6966.5311.76701.027
Financing Cash Flow -0.12628.3020.23662.2980.0570.0130.4160.58635.2710.78273.3249.4541.1334.751-0.0085.9930.6966.5310.53201.027
Other Information:
Effect Of Forex Changes On Cash -0.637-0.108-0.351-0.3390.110.6650.371103.922-103.92272.336-72.3362.446-2.4462.591-2.5912.998-2.9990.125-0.12500.008
Net Change In Cash -15.73-22.782-27.59344.252-15.123-16.237-14.171-18.71632.98970.93462.4039.934-6.0026.002-5.0255.025-5.2665.266-0.26200.262
Cash At End Of Period 17.82133.55156.33383.92639.67454.79871.03585.206103.92270.93472.3369.93406.00205.02505.266000.262